货号:A1177054
同义名:
Activin Receptor-like Kinase 2 Inhibitor 1; Fidrisertib
BLU-782是一种有效且选择性的 ALK2 抑制剂,可在 FOP 小鼠模型中防止水肿和异位骨形成。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Fibrodysplasia ossificans progressive (FOP) is most commonly caused by a highly recurrent autosomal dominant gain-of-function missense mutation in the ACVR1/ALK2 gene which encodes the activin receptor type Ia[1]. BLU-782 is an oral precision therapy specifically designed to selectively target mutant ALK2 with IC50 value of less than 10 nM[2]. BLU-782 was derived from Blueprint Medicines' proprietary compound library and optimized via structure-guided medicinal chemistry for potent and selective targeting of mutant ALK2. BLU-782 demonstrated exquisite selectivity for R206H mutant ALK2 in cellular assays, while sparing closely related anti-targets including ALK1, ALK3, and ALK6. Additionally, BLU-782 potently inhibited mutant ALK2 in vitro, regardless of the activating ligand, including Activin A, Activin B and BMP6. In vivo studies in a conditional knock-in ALK2R206H transgenic mouse model showed BLU-782 prevented the formation of injury-induced HO and edema, as measured by micro computed tomography and magnetic resonance imaging. In addition, BLU-782 prevented the formation of surgery-induced HO following fibular osteotomy surgery in ALK2R206Hmice[3]. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.78mL 0.36mL 0.18mL |
8.89mL 1.78mL 0.89mL |
17.77mL 3.55mL 1.78mL |
|
| CAS号 | 2141955-96-4 |
| 分子式 | C31H42N6O4 |
| 分子量 | 562.7 |
| SMILES Code | O=C(O[C@H]1COCC1)N(CC2)CCN2C(C3=C4)=CC=NN3C=C4C(C=C5)=NC=C5C6(CCN(C(C)C)CC6)OCC |
| MDL No. | MFCD32062780 |
| 别名 | Activin Receptor-like Kinase 2 Inhibitor 1; Fidrisertib; ALK2-IN-1; IPN-60130 |
| 运输 | 蓝冰 |
| InChI Key | SWVYYNLRVIYURK-AREMUKBSSA-N |
| Pubchem ID | 132026427 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 85 mg/mL(151.06 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1